XL-784

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameXL-784
Drug Alias NameXL-784
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsDisintegrin and metalloproteinase domain-containing protein 10 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 10Matrix metalloproteinase-2
Therapy Area/IndicationsAlbuminuriaDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSymphony Evolution Inc
Active IndicationsN/A
Inactive IndicationsAlbuminuriaDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksDrugBank